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Abstract
Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of energy in the form of fatty acids from
intracellular stores of neutral lipids. The enzyme has been shown to exist in different isoforms with different molecular
masses (84 kDa, 89 kDa and 117 kDa) expressed in a tissue-dependent manner, where the predominant 84 kDa form in
adipocytes is the most extensively studied.
Methodology/Principal Findings: In this study we employed negative stain electron microscopy (EM) to analyze the
quarternary structure of the different HSL isoforms. The results show that all three isoforms adopt a head-to-head
homodimeric organization, where each monomer contains two structural domains. We also used enzymatic assays to show
that despite the variation in the size of the N-terminal domain all three isoforms exhibit similar enzymological properties
with regard to psychrotolerance and protein kinase A (PKA)-mediated phosphorylation and activation.
Conclusions/Significance: We present the first data on the quaternary structure and domain organization of the three HSL
isoforms. We conclude that despite large differences in the size of the N-terminal, non-catalytic domain all three HSL
isoforms exhibit the same three-dimensional architecture. Furthermore, the three HSL isoforms are very similar with regard
to two unique enzymological characteristics of HSL, i.e., cold adaptation and PKA-mediated activation.
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Introduction
Hormone-sensitive lipase (HSL) is best known for its role in
mobilizing fatty acids from triacylglycerol stores in adipocyte,
although recent data suggest that it also plays an important role as
a retinyl ester hydrolase [1]. In addition to the predominant, and
most thoroughly investigated 84 kDa isoform found in adipocytes
(HSLadi), HSL also exists in two other isoforms. In testis a
considerably larger isoform of 117 kDa (HSLtes) is expressed [2,3],
and in insulin secreting b-cells an HSL isoform of 89 kDa
(HSLbeta) has been demonstrated [4]. HSLtes appears to be
exclusively expressed in testis [2,3]. HSLbeta, on the other hand,
was cloned from insulin-producing b-cells [4], but is also expressed
in several other cells, including adipocytes. In fact, most HSL-
expressing cells appear to co-express HSLadi and HSLbeta at
different relative levels.
In the HSL gene nine exons, denoted 1–9, encode the sequences
that are common to all three HSL isoforms. Upstream of these,
exons B, A and T are located, each with its own promoter. These
three upstream exons are mutually exclusive and joined to exons
1–9 by alternative splicing, forming transcripts for the functional
HSLadi, HSLbeta and HSLtes isoforms [3,5,6]. Whereas exon B is
non-coding, exon A encodes an additional 43 N-terminal amino
acids of HSLbeta with a high content of positively charged residues
[5]. Exon T encodes an additional 300 amino acid sequence of
HSLtes with an unusually high content of proline and glutamine
residues [3]. The three-dimensional structure has not been solved
for any of the HSL isoforms, but several studies suggest a domain
organization with two major structural domains, a 48 kDa C-
terminal domain containing the active site in an a/b-hydrolase
fold [7,8,9] and a 36 kDa N-terminal domain of HSLadi that has
been shown to complex with fatty acid binding protein
[10,11].
A unique feature among lipases is the regulation of HSL by
reversible protein phosphorylation. This feature has been studied
in extensively for HSLadi. The C-terminal domain comprises, in
addition to the catalytic core, a 150 amino acid regulatory module
including at least four serine phosphorylation sites namely Ser563,
Ser565, Ser659 and Ser660 (HSLadi numbering). In vivo Ser563,
Ser659 and Ser660 are phosphorylated by PKA after stimulation
of lipolysis. In vitro phosphorylation of Ser659 and Ser660 by PKA
has been shown to increase the activity of the enzyme towards lipid
substrates [7,12,13,14,15]. It has also been suggested that HSL
dimerization is induced by phosphorylation [16]. Another unique
feature of HSL is its high relative activity at low temperatures, a
feature that has been suggested to be important in hibernating
animals [17]. The structural basis of this cold adaptation property,
which only has been studied for HSLadi, is not known.
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isoforms with regard to quarternary structure and enzymological
properties. Using negative stain EM we demonstrate that HSL
predominantly exists as a homodimer, where each monomer of the
dimer adopts a two-domain structure. This quarternary structure
is preserved in all three isoforms. Furthermore, we show that the
three isoforms are equally cold adapted and that in vitro
phosphorylation and activation by PKA is not influenced by the
increased size of the N-terminal domains in HSLbeta and HSLtes.
Results
Expression and purification of the three HSL isoforms
All three HSL isoforms were expressed as C-terminally His-
tagged proteins in the baculovirus/insect cell system and purified
by affinity chromatography. The purity of the protein preparations
was approx. 95% for HSLadi and HSLbeta and somewhat lower for
HSLtes as assessed by SDS-PAGE (Figure 1A). The identity of
each isoform preparation was verified by western blot analysis,
using polyclonal antibodies recognizing the sequence encoded by
exons 1–9 of all HSL isoforms or antibodies specifically
recognizing exon A-encoded sequences of HSLbeta or exon T-
encoded sequences of HSLtes (Figure 1, B–D). The specific
activities obtained after purification was measured using pNPB as
substrate. The obtained activities were 113 U/mg for HSLadi,
184 U/mg for HSLbeta and 26.5 U/mg HSLtes. These activites
are lower than those reported for non-tagged rat HSLadi but in
accordance with results for C-terminally His-tagged human and
rat HSLadi [14,15,18].
Transmission electron microscopy analysis
Negative stain EM analysis revealed that all three HSL isoforms
were found predominantly as homodimers (Figure 2A,
Figure 3A and Figure 4A). Each monomer of these homodi-
mers consisted in each case of two structural domains. For the
HSLbeta and HSLadi isoforms the two domains are different in size,
whereas for HSLtes the size of the two domains is similar
(Figure 2, B–C, Figure 3, B–C, Figure 4, B–C and Table 1).
The size distribution of the two domains in each isoform
corresponds to their respective molecular weight. The largest
domain of HSLbeta and HSLadi co-localizes with gold-labelled anti-
his Fab-fragments for HSLadi (Figure 2, D–E) and the smaller
domain with gold-labelled exon A Fab-fragments for HSLbeta
(Figure 3, D–E) indicating that the larger domain of HSLbeta and
HSLadi is the catalytic domain.
In addition to information on the domain structure organization,
the EM images also provided information on the orientation of the
subunits in the HSL dimer. EM images shown in Figure 2 and
Figure 3, indicated that the monomers of the dimer of the smallest
isoform (HSLadi) are oriented in a head-to-head fashion. To further
verify this we used the larger HSLtes isoform, which enabled us to
distinguish twodifferentsized Aulabelswithout loosing the abilityto
observe the protein. Thus, HSLtes was visualized in complex with
3 nm Au particle labelled anti-his antibodies and 5 nm Au particle
labelled antibodies against exon T-derived sequences (Figure 4, F–
G) to verify that the monomers indeed are oriented head-to-head in
the dimeric assembly. Quantification of the TEM images in Figs. 2–
4 showed that for each isoform a head-to-head arrangement of the
two monomers in the dimer was found in 90% of the 600 particles
analyzed (Table 1).
Cold adaptation of HSL isoforms
Earlier reports have shown that HSLadi has a remarkably
conserved enzymatic activity at low temperatures. To test whether
the size of the N-terminal domain had any influence on this
enzymological property the enzymatic activity of all three HSL
isoforms was assayed at 37uC, 25uC, 10uC and 4uC towards the
pNPB substrate. All three isoforms were shown to have a similar
Figure 1. Purity and identity of recombinant HSL isoforms. Purified recombinant proteins were analysed by SDS-PAGE (A) and western blot
(B–D). (A) Lane 1: MWM, lane 2: purified HSLtes, lane 3: purified HSLbeta, lane 4: purified HSLadi. The identity of the respective purified isoforms was
verified by western blot analysis using polyclonal antibodies generated against full-length HSLadi (B), polyclonal antibodies directed against amino
acids encoded by exon A (C), or polyclonal antibodies recognizing the amino acid sequence encoded by exon T (D).
doi:10.1371/journal.pone.0011193.g001
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(Figure 5). The relative activity of lipoprotein lipase was lower
than that of HSL at all temperatures assayed below 37uC.
PKA phosphorylation of HSL isoforms
In order to investigate the extent of background phosphoryla-
tion of HSL purified from Sf9 insect cells, aliquots of preparations
of purified HSL isoforms were incubated with calf intestinal
phosphatase before assaying triglyceride lipase activity. In no
experiment was any effect of this incubation detected on HSL
activity (Figure 6B). This is in agreement with results from
corresponding experiments performed on human HSL purified
from Sf9 cells [14].
The extent of in vitro phosphorylation by PKA of the different HSL
isoforms was investigated by performing phosphorylation experi-
ments in the presence of
32P-labeled ATP. The stoichiometry of the
phosphorylation was 0.22, 0.16 and 0.17 mol phosphate/mol HSL
(Figure 6A). Phosphorylation by PKA increased the activity against
triolein (TO) by 67%, 52% and 74% for the HSLadi,H S L beta and
HSLtesisoforms,respectively(Figure 6C).Bothphosphorylationand
activation levels are in accordance with previously published levels for
his-tagged rat and human HSLadi [14,15]. Since the degree of
activation in absolute terms varied from experiment to experiment,
representative results of several experiments (n=3) are shown in
Figure 6C. In all experiments the activity of the three isoforms
increased in a similar manner after incubation with PKA.
Discussion
The three different HSL isoforms were expressed successfully in
Sf9 insect cells and purified (Figure 1). Using pNPB as substrate
Figure 2. Negative stain electron microscopy analysis of HSLadi.
Electron microscopy images depicting HSLadi either native (A–C) or
with Au-labelled anti-his Fab framents (D–E). Partials (B–E) show either
monomers (B and D) or dimers (C and E) in different orientations. As a
guide to the TEM images, cartoons are included below each subpanel,
showing the large domain in red, the small domain in blue and the
gold-labelled Fab fragment in black. Scale bars are 50 nm (A) and
25 nm (B–E). Au particles have a diameter of 3 nm.
doi:10.1371/journal.pone.0011193.g002
Figure 3. Negative stain electron microscopy analysis of
HSLbeta. Electron microscopy images depicting HSLbeta either native
(A–C) or with Au-labelled anti-exon A Fab fragments (D–E). Partials (B–
E) show either monomers (B and D) or dimers (C and E) in different
orientations. As a guide to the TEM images, cartoons are included
below each subpanel, showing the large domain in red, the small
domain in blue and the gold-labelled Fab fragment in black. Scale bars
are 50 nm (A) and 25 nm (B–E). Au particles have a diameter of 3 nm.
doi:10.1371/journal.pone.0011193.g003
HSL Isoforms
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when comparing the three isoforms, with a remarkably lower
activity of HSLtes compared to both HSLadi and HSLbeta. The
lower activity of the HSLtes preparations is most likely due to the
lower purity obtained for this isoform. Attempts to increase the
purity of this isoform with retained activity were in our hands
unsuccessful. HSLadi and HSLbeta, on the other hand, were
purified to homogeneity with a higher activity of HSLbeta than
HSLadi. The reason for the higher specific activity of HSLbeta
towards pNPB than that of HSLadi is not clear, but the difference
was consistent through all preparations.
Mutagenesis studies of the C-terminal, catalytic domain of
HSLadi has failed to identify the structural basis for the cold
adaptation of HSL and provide an explanation for the more
pronounced cold adaptation of rat HSLadi compared to human
HSLadi [17], raising the possibility that the N-terminal domain
impact the psychrotolerant properties of HSL. We therefore
compared the activities of the three isoforms at decreasing
temperatures. However, our results clearly demonstrate that all
three HSL isoforms exhibit the same degree of psychrotolerance,
suggesting that this feature of HSL indeed is determined by the
catalytic domain. Atomic structures of both rat and human HSL
are needed to confirm this and to identify the structural features
involved in cold adaptation.
It is well established that phosphorylation by PKA in vitro
increases the activity of HSLadi against TO [7,12,14,15]. Recent
studies have shown that the N-terminal domain of HSL docks with
lipid binding proteins in a phosphorylation-dependent manner,
raising the possibility that the size of the N-terminal part of HSL
could modulate HSL activation. Using radiolabelled ATP it was
demonstrated in this study that there were very small, if any,
differences in the degree of in vitro phosphorylation of the three
HSL isoforms, indicating that the size of N-terminal domain does
not influence the interaction between PKA and HSL. Accordingly,
the PKA-mediated in vitro activation was also very similar for the
three isoforms. Thus, it is reasonable to assume that PKA takes
part in the regulation of HSL activity not only in adipocytes and
skeletal muscle, but also in both beta-cells and testis. This in line
with previously published studies illustrating the importance of
PKA in regulation of pancreatic beta-cell function and spermato-
genesis [19,20,21].
The quarternary structure of HSL is well conserved in all
isoforms (Figure 2A, Figure 3A and Figure 4A). Conservation
of a homodimeric structure is consistent with the concept that
dimerization is important for HSL function and the smallest
functional unit of HSL could thus be the homodimer. In addition,
it was shown, with the aid of different sized gold labels on two
different Fab fragments, that the monomers in the homodimer are
arranged in a head-to-head fashion (Figure 4, F–G). This is in
contrast to what has previously been shown for two other
mammalian lipases, lipoprotein lipase and endothelial lipase,
where the two monomers in the dimer are oriented in a head-to-
tail fashion, where a lipid-binding, non-catalytic C-terminal
domain, presents the lipid substrate to the catalytic domain of
the other monomer of the dimer [22,23]. The observation that the
degree of dimerization of the HSL preparations was very high,
despite that little background phosphorylation was observed,
argues against that dimerization of HSL is brought about by
phosphorylation as previously suggested [16].
Even though we did not find any differences between the
different HSL isoforms with regard to the structural and
enzymological properties studied here, it is possible, or even
likely, that functional differences exist. One possibility is that the
N-terminal domain is involved in protein-protein interactions
Figure 4. Negative stain electron microscopy analysis of HSLtes.
Electron microscopy images depicting HSLtes either native (A–C) or
with Au-labelled anti-His-Fab fragments only (D and E) or in
combination with Au-labelled anti-exon T- Fab fragments (F and G).
Partials (B–G) show either monomers (B, D and F) or dimers (C, E and
G) in different orientations. As a guide to the TEM images, cartoons are
included below each subpanel, showing the domain corresponding to
the large domain in Figs. 2 and 3in red, the other domain in green and
the gold-labelled antibodies in black. Scale bars are 50 nm (A) and
25 nm (B–G). Au particles have a diameter of 3 nm (Anti-His6)o r5n m
(Anti-exon T).
doi:10.1371/journal.pone.0011193.g004
HSL Isoforms
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ments. The N-terminal domain of HSLadi has in fact been shown
to interact with FABP. Depending on the hormonal status of the
adipocyte, HSLadi is located either in the cytsol (hormonally
queiscent cells) or at the lipid droplet (b-adrenergic stimulation)
[24], whereas HSLbeta has been found to be located in close
association to insulin granules of b-cells [5]. The subcellular
localization of HSLtes is not known, but based on studies
performed in HSL null mice it can be speculated that HSLtes is
indirectly associated with the membrane in haploid germ cells,
where it controls cholesterol deposition and thus membrane
fluidity [25].
In conclusion, we here present the first data of the quarternary
structure of HSL. All three known HSL isoforms exhibit a
homodimeric structure with a head-to-head orientation of the two
monomers, and with two major structural domains in each
monomer. We also demonstrate that despite large variations in the
size of the N-terminal domain do the three HSL isoforms exhibit
the same degree of psychrotolerance and the same degree of PKA-
mediated phosphorylation and activation in vitro. These results
suggest that the N-terminal domain of HSL may only play a role
in modulating the in vivo activity of HSL, for instance through
mediation of protein-protein interactions.
Materials and Methods
Generation of recombinant baculovirus transfer vectors
The 59-sequences of HSLtes and HSLbeta cDNA [3,5] were
obtained by PCR using the antisense primer 59-ATA GAC TCC
GTA AGC GCC CAG AAT-39, the sense primers 59-CAC AGG
ATC CAG GAT GAA ACC TAG GAG ACC-39 (BamHI) and
59-GTG GAT CCA TGG AGC CGG CCG TGG AAT C-39
(BamHI), respectively, and the corresponding cDNA as template.
The obtained PCR products were digested using BamHI and each
subcloned into the previously described pVL1393-HSLadi-
His8[15]
Insect cell culture, transfection and expression of HSL
isoforms
Sf9 insect cells (BD Pharmingen) were maintained in suspension
culture at 27uC and 117 rpm in Sf-900 II SFM medium (Gibco-
BRL) supplemented with 4% foetal calf serum (Gibco-BRL) and
100 U/ml penicillin/streptomycin (Gibco-BRL). Transfection of
Sf9 cells was performed using the BaculoGold
TM Transfection Kit
(BD Pharmingen) according to the manufacturer’s instructions.
Plaque purification was performed and high titre virus stocks
generated using standard procedures. Protein expression was
performed according to [26].
Purification procedures
Cells expressing either HSLbeta or HSLadi were harvested by
centrifugation (1200 g, 10 min), and resuspended in lysis buffer
(40 mm Tris/HCl, pH 7.9, 1 mM b-mercaptoethanol, 1%
C13E12, 10% glycerol, 20 mg/l leupeptin, 10 mg/l antipain
and 1.0 mg/l pepstatin). The cell suspension was gently sonicated
and centrifuged for 45 min at 4uC and 50 000 g.
Following addition of imidazole and NaCl to final concentra-
tions of 5 mM and 0.3 M, respectively, the cell supernatant was
mixed with Ni-NTA agarose (Qiagen) pre-equlillibrated in buffer
A (20 mM Tris/HCl, pH 7.9, 0.3 M NaCl, 5 mM imidazole,
10% glycerol, 0.1% C13E12,2 0mg/l leupeptin, 10 mg/l antipain
and 1.0 mg/l pepstatin). The Ni-NTA agarose and the applied
supernatant were gently agitated for 60 min at 10uC followed by
low-speed centrifugation and removal of the supernatant. The Ni-
NTA slurry was washed twice in 10 volumes of buffer A containing
60 mM imidazole. Protein was subsequently eluted in buffer A
containing 250 mM imidazole.
For purification of HSLtes an alternate procedure was used.
Instead of Ni-NTA agarose the cell supernatant was mixed with a
TALON Resin (BD Biosciences), equilibrated in buffer T (0.25 M
sucrose, 5 mM Tris/HCl, pH 7.9, 0.3 M NaCl, 5 mM imidazole,
1% C13E12,1m Mb-ME, 20 mg/l leupeptin, 10 mg/l antipain,
1.0 mg/l pepstatin). After gentle agitation for 60 min at 10uC the
resin was washed in 10 volumes of buffer T and 10 volumes of
buffer T containing 7.5 mM imidazole. Protein was subsequently
eluted in buffer T containing 100 mM imidazole.
Following purification the respective elution buffers were
immediately exchanged for 10 mM Tris/HCl, pH 7.3, 0.14 M
NaCl, 10% glycerol, 0.2% C13E12,1m Mb-ME using a PD-10
desalting column (Amersham Biosciences). Protein concentration
in preparations was determined using the 2-D Quant Kit
(Amersham Biosciences).
Antibodies for western blot
As primary antibody for all HSL isoforms a polyclonal rabbit
anti-HSL antibody raised against the amino acid sequence
encoded by exons 1–9 of rat HSL [8] was used. HSLbeta was
selectively detected using a polyclonal rabbit antibody raised
Table 1. Quantification of TEM images (Figs. 2–4).
HSL isoform Large domain Small domain
Head-to-head
arrangement (by
immunogold)
HSLadi 6+/21n m 4 +/21 nm 89.5%
HSLbeta 6+/21n m 4 +/21 nm 92.7%
HSLtes 6+/22n m 6 +/22 nm 90.2%
For each HSL isoform 600 particles were analyzed with regard to size of the two
structural domains in the monomer and for presence of a head-to-head
arrangement of the dimer. Large and small domain refer to the situation in
HSLadi and HSLbeta, where the labeling pattern shows that the larger domain
corresponds to the C-terminal catalytic domain and the small domain to the N-
terminal non-catalytic domain.
doi:10.1371/journal.pone.0011193.t001
Figure 5. Cold adaptation of HSL isoforms. Esterase activity
towards the p-nitrophenolbutyrate (pNPB) substrate of the three HSL
isoforms and bovine lipoprotein lipase (LPL) at different assay
temperatures. Results shown are mean 6 SEM of seven or eight
experiments (HSL isoforms) or two experiments (LPL) in triplicate.
doi:10.1371/journal.pone.0011193.g005
HSL Isoforms
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HSLtes a polyclonal antibody against exon T-derived sequences
was used [27].
Transmission electron microscopy (TEM) and immuno-
EM of HSL isoforms
The domain structure organization of the different HSL
isoforms was analyzed by negative staining and transmission
electron microscopy as described previously [28]. Fab fragments of
antibodies against the His-tag (Qiagen) and the exon A-encoded
sequence, respectively, were conjugated with 3 nm colloidal Au.
Fab fragments of antibodies against the exon T-encoded sequence
were conjugated with 5 nm colloidal Au [29]. HSL aliquots were
mixed with the Au conjugates and incubated for 1 h at 4uC. Five
microliter aliquots were adsorbed onto carbon-coated grids for
1 min, washed with two drops of water, and stained on two drops
of 0.75% uranyl formate. The grids were rendered hydrophilic by
glow discharge at low pressure in air. Specimens were observed in
a JEOL JEM 1230 electron microscope operated at 80 kV
accelerating voltage, and images were recorded with a Gatan
Multiscan 791 CCD camera.
HSL activity assays
HSL lipase activity was measured against phospholipid-
stabilized emulsions of tri[
3H]oleoylglycerol (TO) as previously
described [8,15,30,31]. Esterase activity of the HSL isoforms was
measured using para-nitrophenyl (pNPB) butyrate as substrate
(Sigma). For the temperature dependence experiments, assays
were performed according to [32]. Assay conditions for purified
bovine lipoprotein lipase [33] were adjusted according to [34].
PKA phosphorylation of HSL isoforms
Four to six mg of the respective HSL isoform was phosphor-
ylated essentially as described [15] with the exception that the
buffer used in reactions was 50 mM Tris pH 8, 300 mM NaCl,
10% glycerol, 0.2% C13E12, 1 mM DTT, 0.2 mM ATP, 0.5 mCi/
ml[ 2
32P] ATP and 10 mM MgCl2, 0.25 U/ml PKA (New
England Biolabs) supplemented with a cocktail of protease
inhibitors (Roche Complete). Radiolabeled ATP was omitted in
reactions used for activity assays. Dephosphorylation was per-
formed as described in [14] with the exception that the reaction
buffer was 50 mM Tris pH 8, 300 mM NaCl, 10% glycerol, 0.2%
C13E12, 1 mM DTT, 10 mM MgCl2, 0.2 U/ml calf intestinal
phosphatase (CIAP, Fermentas) supplemented with a cocktail of
protease inhibitors (Roche Complete). Samples used for activity
assays were assayed after 1 h of incubation with PKA or CIAP.
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